Correlating ISEND and Tumor Mutation Burden (TMB) with Clinical Outcomes of Advanced Non-Small Cell Lung Cancer (ANSCLC) Patients on Nivolumab

被引：0
|
作者：
Park, W. [1 ]
Lopes, G. [1 ]
Kwon, D. [2 ]
Florou, V. [1 ]
Chae, Y. K. [3 ]
Warsch, J. [4 ]
Ishkanian, A. [5 ]
Jahanzeb, M. [6 ]
Mudad, R. [1 ]
机构：
[1] Univ Miami, Sylvester Comprehens Canc Ctr, Hematol & Oncol, Miami, FL USA
[2] Univ Miami, Sylvester Comprehens Canc Ctr, Dept Med Biostat & Bioinformat, Miami, FL USA
[3] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Div Hematol Oncol, Dev Therapeut Program, Chicago, IL 60611 USA
[4] Univ Miami, Sylvester Comprehens Canc Ctr, Radiol, Miami, FL USA
[5] Univ Miami, Sylvester Comprehens Canc Ctr, Radiat Oncol, Miami, FL USA
[6] Univ Miami, Sylvester Comprehens Canc Ctr, Med Oncol, Miami, FL USA
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 11期
关键词：
Tumor mutation burden; biomarker; Nivolumab;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.07-025
引用
收藏
页码：S2004 / S2005
页数：2
相关论文
共 50 条
  • [41] Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer
    Enomoto, T.
    Tamiya, A.
    Matsumoto, K.
    Adachi, Y.
    Azuma, K.
    Inagaki, Y.
    Kouno, S.
    Taniguchi, Y.
    Saijo, N.
    Okishio, K.
    Atagi, S.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2021, 23 (03) : 582 - 590
  • [42] Endocrinological Side-Effects of Nivolumab in Advanced Non-Small Cell Lung Cancer
    Rossi, Giovanni
    Albertelli, Manuela
    Nazzari, Elena
    Rijavec, Erka
    Genova, Carlo
    Barletta, Giulia
    Biello, Federica
    Maggione, Claudia
    Dal Bello, Maria Giovanna
    Ferone, Diego
    Grosse, Francesco
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1297 - S1298
  • [43] Nivolumab for advanced non-small cell lung cancer: an evaluation of a phase III study
    Ulmeanu, Ruxandra
    Antohe, Ileana
    Anisie, Ecaterina
    Antoniu, Sabina
    EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (02) : 165 - 167
  • [44] Tumor Mutation Score Is More Powerful Than Tumor Mutation Burden in Predicting Response to Immunotherapy in Non-Small Cell Lung Cancer
    Li, Y.
    Chen, Z.
    Wu, L.
    Tao, W.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S724 - S724
  • [45] Nivolumab treatment beyond progressive disease in advanced non-small cell lung cancer
    Takatoshi Enomoto
    Akihiro Tamiya
    Kinnosuke Matsumoto
    Yuichi Adachi
    Koji Azuma
    Yuji Inagaki
    Shunichi Kouno
    Yoshihiko Taniguchi
    Nobuhiko Saijo
    Kyoichi Okishio
    Shinji Atagi
    Clinical and Translational Oncology, 2021, 23 : 582 - 590
  • [46] Clinical and Plasma Biomarkers for Disease Control with Nivolumab Treatment for Advanced Non-Small Cell Lung Cancer (NSCLC)
    Daher, Sameh
    Lawrence, Yaacov
    Dudnik, Elizabeth
    Hanovich, Ekaterina
    Urban, Damien
    Peled, Nir
    Navon, Rossie
    Leibowitz-Amit, Raya
    Hammerman, Ariel
    Battat, Erez
    Bar, Jair
    Onn, Amir
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S1307 - S1307
  • [47] Evaluation of the lung immune prognostic index in advanced non-small cell lung cancer patients under nivolumab monotherapy
    Ruiz-Banobre, Juan
    Areses-Manrique, Maria C.
    Mosquera-Martinez, Joaquin
    Cortego, Alexandra
    Afonso-Afonso, Francisco J.
    de Dios-Alvarez, Noemi
    Fernandez-Nunez, Natalia
    Azpitarte-Raposeiras, Cristina
    Amenedo, Margarita
    Santome, Lucia
    Luis Firvida-Perez, Jose
    Garcia-Campelo, Rosario
    Garcia-Gonzalez, Jorge
    Casal-Rubio, Joaquin
    Vazquez, Sergio
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 1078 - +
  • [48] Update on targeted therapies for advanced non-small cell lung cancer: nivolumab in context
    Le, Alexander D.
    Alzghari, Saeed K.
    Jean, Gary W.
    La-Beck, Ninh M.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2017, 13 : 223 - 236
  • [49] Clinical and technical insights of tumour mutational burden in non-small cell lung cancer
    Meri-Abad, Marina
    Moreno-Manuel, Andrea
    Garcia, Sandra Gallach
    Calabuig-Farinas, Silvia
    Perez, Rafael Sirera
    Herrero, Carlos Camps
    Jantus-Lewintre, Eloisa
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2023, 182
  • [50] Clinical Characteristics of Liver Metastasis in Nivolumab-treated Patients with Non-small Cell Lung Cancer
    Shiroyama, Takayuki
    Suzuki, Hidekazu
    Tamiya, Motohiro
    Tamiya, Akihiro
    Tanaka, Ayako
    Okamoto, Norio
    Nakahama, Kenji
    Taniguchi, Yoshihiko
    Isa, Shun-Ichi
    Inoue, Takako
    Imamura, Fumio
    Atagi, Shinji
    Hirashima, Tomonori
    ANTICANCER RESEARCH, 2018, 38 (08) : 4723 - 4729
12345